Mechanisms of resistance to telithromycin in Streptococcus pneumoniaeHISANAGA, Tamiko; HOBAN, Daryl J; ZHANEL, George G et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 3, pp 447-450, issn 0305-7453, 4 p.Article

Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in CanadaNICHOL, Kimberly A; ZHANEL, George G; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 2, pp 804-808, issn 0066-4804, 5 p.Article

Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobialHOBAN, Daryl J; BOUCHILLON, Samuel K; DOWZICKY, Michael J et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 4, pp 423-428, issn 0732-8893, 6 p.Article

Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeNICHOL, Kimberly A; ZHANEL, George G; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 10, pp 3261-3264, issn 0066-4804, 4 p.Article

Nitrofurantoin is active against vancomycin-resistant enterococciZHANEL, George G; HOBAN, Daryl J; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 324-326, issn 0066-4804Article

In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniaeZHANEL, George G; WALTERS, Michael; LAING, Nancy et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 47, Num 4, pp 435-440, issn 0305-7453Article

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia : pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniaeNOREDDIN, Ayman M; HOBAN, Daryl J; ZHANEL, George G et al.International journal of antimicrobial agents. 2005, Vol 26, Num 2, pp 120-125, issn 0924-8579, 6 p.Article

Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care unitsBAUDRY, Patricia J; MATASEJE, Laura; ZHANEL, George G et al.Diagnostic microbiology and infectious disease. 2009, Vol 65, Num 4, pp 379-383, issn 0732-8893, 5 p.Article

Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimensKARLOWSKY, James A; KASLOFF, Sam; NICHOL, Kim A et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 3, pp 283-287, issn 0732-8893, 5 p.Article

Comparative Pharmacodynamics of Garenoxacin, Gemifloxacin, and Moxifloxacin in Community-Acquired Pneumonia Caused by Streptococcus pneumoniae : A Monte Carlo Simulation AnalysisNOREDDIN, Ayman M; REESE, Angela A; OSTROSKI, Melissa et al.Clinical therapeutics. 2007, Vol 29, Num 12, pp 2685-2689, issn 0149-2918, 5 p.Article

Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolatesSMITH, Heather J; WALTERS, Michael; HISANAGA, Tamiko et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3954-3958, issn 0066-4804, 5 p.Article

Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999 : Prevalence of mef(A) and erm(B) and susceptibilities to ketolidesHOBAN, Daryl J; WIERZBOWSKI, Aleksandra K; NICHOL, Kim et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 7, pp 2147-2150, issn 0066-4804Article

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009HAWSER, Stephen P; BOUCHILLON, Samuel K; HOBAN, Daryl J et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 3, pp 219-224, issn 0924-8579, 6 p.Article

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)HOBAN, Daryl J; BIEDENBACH, Douglas J; MUTNICK, Alan H et al.Diagnostic microbiology and infectious disease. 2003, Vol 45, Num 4, pp 279-285, issn 0732-8893, 7 p.Article

Stretching the mutant prevention concentration (MPC) beyond its limitsSMITHS, Heather J; NICHOL, Kimberly A; HOBAN, Daryl J et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 6, pp 1323-1325, issn 0305-7453, 3 p.Article

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009-2011BOUCHILLON, Sam K; BADAL, Robert E; HOBAN, Daryl J et al.Clinical therapeutics. 2013, Vol 35, Num 6, pp 872-877, issn 0149-2918, 6 p.Article

Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniaeSCHUREK, Kristen N; ADAM, Heather J; HOBAN, Daryl J et al.International journal of antimicrobial agents. 2006, Vol 28, Num 3, pp 266-269, issn 0924-8579, 4 p.Article

In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida speciesKARLOWSKY, James A; HOBAN, Daryl J; ZHANEL, George G et al.International journal of antimicrobial agents. 2006, Vol 27, Num 2, pp 174-177, issn 0924-8579, 4 p.Article

Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolidesWIERZBOWSKI, Aleksandra K; BOYD, Dave; MULVEY, Michael et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4635-4640, issn 0066-4804, 6 p.Article

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide- resistant Streptococcus pneumoniae for which telithromycin MICs varyZHANEL, George G; JOHANSON, Christel; LAING, Nancy et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 1943-1948, issn 0066-4804, 6 p.Article

Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claimsSMITH, Heather J; NICHOL, Kimberly A; HOBAN, Daryl J et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 49, Num 6, pp 893-895, issn 0305-7453Article

Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutantsSMITH-ADAM, Heather J; NICHOL, Kimberly A; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 846-848, issn 0066-4804, 3 p.Article

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across CanadaZHANEL, George G; WALKTY, Andrew; NICHOL, Kim et al.Diagnostic microbiology and infectious disease. 2003, Vol 45, Num 1, pp 63-67, issn 0732-8893, 5 p.Article

Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010HOBAN, Daryl J; NICOLLE, Lindsay E; HAWSER, Stephen et al.Diagnostic microbiology and infectious disease. 2011, Vol 70, Num 4, pp 507-511, issn 0732-8893, 5 p.Article

Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008HAWSER, Stephen P; BADAL, Robert E; BOUCHILLON, Samuel K et al.Journal of medical microbiology. 2010, Vol 59, Num 9, pp 1050-1054, issn 0022-2615, 5 p.Article